Literature DB >> 21381037

Surgical options for localized and advanced gastrointestinal stromal tumors.

Timothy L Frankel1, Alfred E Chang, Sandra L Wong.   

Abstract

The development of imitinab has led to a revolution in the management of gastrointestinal stromal tumors (GIST), but surgical resection remains the cornerstone of treatment for patients with localized disease. The principles to surgical treatment of GIST include careful handling of tissues to prevent tumor rupture and resection to negative margins without the need for wide excision. Minimally invasive techniques have proven equally efficacious provided appropriate oncologic resections are performed.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21381037     DOI: 10.1002/jso.21892

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Spontaneous Peritoneal Rupture of Gastric Stromal Tumor.

Authors:  Kutay Sağlam; Serdar Topaloğlu; Mithat Kerim Arslan; Sevdegül Mungan; Adnan Çalık
Journal:  J Gastrointest Cancer       Date:  2017-03

Review 2.  [Gastrointestinal stromal tumors: diagnostics and therapy].

Authors:  V Fendrich; D K Bartsch
Journal:  Chirurg       Date:  2014-06       Impact factor: 0.955

3.  Gastrointestinal stromal tumors: case series of 29 patients defining the role of imatinib prior to surgery.

Authors:  Shailesh V Shrikhande; Sachin S Marda; Kunal Suradkar; Supreeta Arya; Guruprasad S Shetty; Munita Bal; Parul J Shukla; Mahesh Goel; K M Mohandas
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

4.  Outcomes After Surgical Resection Differ by Primary Tumor Location for Metastatic Gastrointestinal Stromal Tumors (GISTs): a Propensity Score Matching Population Study.

Authors:  Apostolos Gaitanidis; Michail Alevizakos; Alexandra Tsaroucha; Michail Pitiakoudis
Journal:  J Gastrointest Cancer       Date:  2019-12

5.  Laparoscopic-endoscopic cooperative surgery for gastric submucosal tumors.

Authors:  Wei-Ming Kang; Jian-Chun Yu; Zhi-Qiang Ma; Zi-Ran Zhao; Qing-Bin Meng; Xin Ye
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

6.  Gastrointestinal Bleeding Is an Independent Risk Factor for Poor Prognosis in GIST Patients.

Authors:  Qi Liu; Yuji Li; Ming Dong; Fanmin Kong; Qi Dong
Journal:  Biomed Res Int       Date:  2017-05-15       Impact factor: 3.411

Review 7.  Gastrointestinal stromal tumors: A multidisciplinary challenge.

Authors:  Juan Manuel Sanchez-Hidalgo; Manuel Duran-Martinez; Rafael Molero-Payan; Sebastian Rufian-Peña; Alvaro Arjona-Sanchez; Angela Casado-Adam; Antonio Cosano-Alvarez; Javier Briceño-Delgado
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

8.  Resection of the gastric submucosal tumor (G-SMT) originating from the muscularis propria layer: comparison of efficacy, patients' tolerability, and clinical outcomes between endoscopic full-thickness resection and surgical resection.

Authors:  Sha Liu; Xinxin Zhou; YongXing Yao; Keda Shi; Mosang Yu; Feng Ji
Journal:  Surg Endosc       Date:  2020-02-03       Impact factor: 4.584

9.  Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib.

Authors:  Xiaodong Gao; Anwei Xue; Yong Fang; Ping Shu; Jiaqian Ling; Jing Qin; Yingyong Hou; Kuntang Shen; Yihong Sun; Xinyu Qin
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

10.  Tumor rupture of gastric gastrointestinal stromal tumors during endoscopic resection: a risk factor for peritoneal metastasis?

Authors:  Shiyi Song; Wei Ren; Yi Wang; Shu Zhang; Song Zhang; Fei Liu; Qiang Cai; Guifang Xu; Xiaoping Zou; Lei Wang
Journal:  Endosc Int Open       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.